Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
244.5 INR | -2.32% | -1.48% | 0.00% |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 3,994 | 4,353 | 6,128 | 7,846 |
EBITDA 1 | 192.5 | 438.4 | 561.5 | 755 |
EBIT 1 | 174 | 415.1 | 534.8 | 720.7 |
Operating Margin | 4.36% | 9.54% | 8.73% | 9.19% |
Earnings before Tax (EBT) 1 | 191.1 | 412 | 574.5 | 766.9 |
Net income 1 | 129.6 | 234.4 | 400 | 549.4 |
Net margin | 3.24% | 5.38% | 6.53% | 7% |
EPS 2 | 4.080 | 7.389 | 12.61 | 17.32 |
Free Cash Flow | - | -229.4 | -266.6 | 8.085 |
FCF margin | - | -5.27% | -4.35% | 0.1% |
FCF Conversion (EBITDA) | - | - | - | 1.07% |
FCF Conversion (Net income) | - | - | - | 1.47% |
Dividend per Share | - | - | - | - |
Announcement Date | 1/6/23 | 1/6/23 | 1/6/23 | 9/19/23 |
Balance Sheet Analysis
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | 517 | 693 | 881 | 665 |
Net Cash position 1 | - | - | - | - |
Leverage (Debt/EBITDA) | 2.686 x | 1.581 x | 1.569 x | 0.8811 x |
Free Cash Flow | - | -229 | -267 | 8.09 |
ROE (net income / shareholders' equity) | - | 27.5% | 31.3% | 30.7% |
ROA (Net income/ Total Assets) | - | 14.4% | 14.1% | 16% |
Assets 1 | - | 1,623 | 2,837 | 3,427 |
Book Value Per Share 2 | 26.80 | 34.20 | 48.10 | 65.50 |
Cash Flow per Share 2 | 0.2200 | 1.480 | 1.850 | 1.120 |
Capex 1 | 54.1 | 53.8 | 89.7 | 98.9 |
Capex / Sales | 1.35% | 1.24% | 1.46% | 1.26% |
Announcement Date | 1/6/23 | 1/6/23 | 1/6/23 | 9/19/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
0.00% | 117M | |
+62.11% | 840B | |
+39.84% | 621B | |
-5.56% | 354B | |
+16.52% | 319B | |
+7.87% | 297B | |
+13.94% | 237B | |
+15.82% | 221B | |
+1.84% | 220B | |
+11.40% | 169B |
- Stock Market
- Equities
- JGCHEM Stock
- Financials J.G. Chemicals Limited